Financings in Brief: Bio-Vascular Inc.
This article was originally published in The Gray Sheet
Executive Summary
Bio-Vascular Inc.: Adopts shareholder rights plan "to protect the company and its shareholders from unsolicited attempts or inequitable offers to acquire the company." The company will make a dividend distribution on July 15, 1996 of one common share purchase right for each outstanding share of the company. Rights become exercisable following the acquisition of 15% or more of the company's common stock or initiation of a tender offer that would "result in ownership by the person or group of 15 percent or more of the company's common stock". Bio-Vascular says it is "not aware" of any specific effort to acquire control of the company...
You may also be interested in...
‘Clear’ Is In The Eye Of The Beholder, New York, CRN Argue In Age-Restricted Sales Litigation
CRN’s request for clarification, as it continues litigating complaint in US District Court for Southern New York, highlights what it contends is vague and overly general language in the legislation passed in October with a 22 April effective date.
Biogen Sees Improving Momentum In Slow Leqembi Launch
Sales of the company’s new drugs have a lot of growing to do to make up for older products’ declines, but Biogen highlighted signs of strength for new launches in its Q1 report.
Vivalink Partners With Rett Syndrome Research Trust To Accelerate Research In Rare Disease
Vivalink will provide ECG wearable technology to monitor patients in RSRT’s Vibrant study, which is aimed at assessing autonomic dysfunction in children with Rett syndrome.